🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DXC
$DXCM
🔒 US EquitiesDexCom, Inc.
AVG HISTORICAL GAP
-2.64%
MAX GAP RECORD
-38.80%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DXCM
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DXCM
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (AFTER CLOSE (16:00)) |
+1.99%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE) |
+7.16%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE) |
+2.42%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (AFTER CLOSE) |
-0.97%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (AFTER CLOSE) |
-13.21%
|
| Jul 30, 2025 Earnings Release 2025-07-30 (AFTER CLOSE) |
-3.77%
|
| Apr 24, 2025 Earnings Release 2025-04-24 (AFTER CLOSE) |
+0.10%
|
| Feb 06, 2025 Earnings Release 2025-02-06 (BEFORE OPEN) |
+0.08%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.3%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (6)
📖 Intelligence Summary
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6,…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗